St. Baldrick’s Foundation launches month-long campaign for Childhood Cancer Awareness Month to give kids with cancer the treatment options they deserve
LOS ANGELES (September 4, 2018) – When a child is diagnosed with cancer, their family is presented with treatment options – often a combination of surgery, radiation and chemotherapy. Radiation and chemotherapy have been used to treat kids’ cancers for more than 50 years and often come with long-term late effects including secondary cancers, heart damage and cognitive issues. Often a child’s best chance at survival is a clinical trial which offers them the newest treatment options available.
In recognition of Childhood Cancer Awareness Month, the St. Baldrick’s Foundation will highlight the critical need to fund lifesaving research and share stories of kids affected by cancer – like Micah, who is alive today because there was a clinical trial available.
September's Childhood Cancer Awareness Month. Give kids with cancer more treatment options by donating to @StBaldricks #CCAM Tweet
In March 2012, when Micah was one day shy of 15 months old, an initial diagnosis of pneumonia led to the discovery of high-risk neuroblastoma. Doctors found tumor activity in his abdomen, chest, arm and leg bones, and his bone marrow. Since his initial diagnosis, Micah has relapsed twice and participated in five clinical trials, including a St. Baldrick’s-funded trial for Unituxin.
“As the largest charitable funder of childhood cancer research grants, St. Baldrick’s is proud to fund every stage of the research process, from basic research in the lab to clinical trials with patients,” said Kathleen Ruddy, CEO of the St. Baldrick’s Foundation. “While fewer than 5 percent of adults with cancer are enrolled on a clinical trial, more than half of childhood cancer patients are. Through a yearly multimillion-dollar grant to the Children’s Oncology Group (COG) and other research grants, St. Baldrick’s is proud to have supported more than 250 clinical trials involving more than 100,000 patients.”
The average cost for a COG institution to treat a child on a clinical trial is $10,000. The U.S. National Cancer Institute reimburses $2,250 per patient, and the St. Baldrick’s Foundation adds another $1,000. Because of this support, more kids have access to clinical trials and can be treated closer to home.
About St. Baldrick’s Foundation
As the largest private funder of childhood cancer research grants, the St. Baldrick’s Foundation is leading the charge to take childhood back from cancer. St. Baldrick’s funds some of the most brilliant childhood cancer research experts who are working to find cures and better treatments for all childhood cancers. Kids need treatments as unique as they are – and that starts with funding research just for them. Join us at StBaldricks.org to help support the best childhood cancer research, no matter where it takes place.